Clinical Trials Sponsored by Kaneka Pharma America LLC

Total 33 results

Kaneka Medical America LLC

Recruiting

Kaneka Endovascular Embolization and Protection (KEEP)

Aneurysm Cerebral

United States
Kaneka Medical America LLC

Recruiting

Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Dialysis Amyloidosis

United States
Kaneka Medical America LLC

Recruiting

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children (FSGS pediatric)

Focal Segmental Glomerulosclerosis

United States
Kaneka Medical America LLC

Recruiting

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System (FSGSALLAGE)

Focal Segmental Glomerulosclerosis

United States
Emory University
Kaneka Medical America LLC

Completed

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers (INFLAME)

Familial Hypercholesterolemia

United States
Massachusetts General Hospital
Kaneka Medical America LLC

Completed

Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery (RAAPID-II)

Preeclampsia

Germany, United States
Massachusetts General Hospital
Kaneka Medical America LLC

Unknown

Assessing Bioavailability of CoQ10 Supplementation in Burn Patients (CoQ10)

Burn Injury

United States
Children's Hospital Medical Center, Cincinnati
Kaneka Medical America LLC

Completed

LDL-Apheresis for FSGS CardioRenal Outcomes

Focal Segmental Glomerulosclerosis

United States
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC

Completed

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

Cardiac Arrest

United States
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC

Completed

Ubiquinol (Reduced COQ10) for Patients With Sepsis

Sepsis

United States
Sucampo Pharma Americas, LLC

Completed

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

Osteoarthritis | Rheumatoid Arthritis | Ulcers | NSAID-induced Gastroduodenal Injury

United States
Sucampo Pharma Americas, LLC

Completed

Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

Opioid-Induced Bowel Dysfunction

United States, Canada
Sucampo Pharma Americas, LLC

Terminated

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Oral Mucositis

United States
Sumitomo Pharma America, Inc.
BehaVR LLC

Completed

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. (BVR-100-102)

Social Anxiety Disorder (SAD)

United States
Sucampo Pharma Americas, LLC
Takeda

Completed

Lubiprostone for Children With Constipation

Constipation - Functional

United States, United Kingdom, Netherlands, Poland, Belgium, France, Canada
Sucampo Pharma Americas, LLC
Takeda

Completed

Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome With Constipation
Sucampo Pharma Americas, LLC
Takeda

Completed

Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers

Healthy Volunteers

United States
Patrick Moriarty, MD, FACP, FACC
Kaneka Medical America LLC

Completed

Treating Congestive Heart Failure Using a Device to Remove Cholesterol

Heart Decompensation

United States
Sucampo Pharma Americas, LLC
Sucampo AG

Completed

Lubiprostone in Children With Functional Constipation

Constipation - Functional

United States, United Kingdom, Canada, Netherlands, Poland, Belgium, France
Sucampo Pharma Americas, LLC
Sucampo AG

Completed

Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation

Constipation - Functional

United States
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome | Constipation
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone (OPAL)

Opioid-Induced Bowel Dysfunction

United States, Canada
Tokai University
Abbott Medical Devices; Kaneka Medical America LLC; Terumo Medical Corporation; Asahi Intech and other collaborators

Completed

Guidewire for Chronic Total Occlusion (G-FORCE)

Coronary Occlusion

Japan
Sucampo Pharma Americas, LLC
Takeda; Sucampo AG

Terminated

Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Mallinckrodt
Takeda; Sucampo Pharma Americas, LLC; Sucampo AG

Completed

Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration

Dry Age-related Macular Degeneration

Austria
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)

Opioid-Induced Bowel Dysfunction

United States, Canada
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

Opioid-induced Bowel Dysfunction

United States, Czechia, Germany, Belgium, Poland, Sweden, United Kingdom
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation

Constipation

United States
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension

Portal Hypertension

United States
Sucampo Pharma Americas, LLC
Sucampo AG; Sucampo Pharmaceuticals, Inc.

Completed

Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

Chronic Idiopathic Constipation

United States
Nova Immunotherapeutics Limited
The Emmes Company, LLC; Nova Laboratories Limited; Mercia Pharma Inc.

Unknown

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) (MER4101)

Influenza, Human

United States
Żelazna Medical Centre, LLC
Charles University, Czech Republic; Karolinska Institutet; Charite University... and other collaborators

Unknown

Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic (MindCOVID)

Depression | Anxiety | Pregnancy Related

Lebanon, Hong Kong, United States, Sweden, Germany, Australia, Poland, Italy, Taiwan, Albania, Czechia, France, Israel, Norway, Spain

Clinical Trials Sponsored by Kaneka Pharma America LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations